FTC probing drug distributors over low supplies of chemotherapies, WSJ reports

The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by hospital purchasing groups and drug distributors, reported The Wall Street Journal’s Liz Essley Whyte. Publicly traded drug distributors include Cencora (COR), Cardinal Health (CAH) and McKesson (MCK).